Directional atherectomy
Clinical evidence
Explore clinical studies and evidence that evaluate the effectiveness and safety of our directional atherectomy technologies.
The most comprehensive review of atherectomy literature for peripheral endovascular interventions to date found a large volume of published literature, with more than 300 papers, many representing the highest levels of evidence.
This study shows how the use of the HawkOne™ directional atherectomy system, followed by the IN.PACT™ Admiral™ drug-coated balloon, can achieve positive outcomes in treating peripheral artery disease.
A head-to-head look at directional atherectomy versus orbital atherectomy in a single-center, randomized controlled trial
DEFINITIVE LE is the largest independently adjudicated study of peripheral atherectomy conducted to date. It provides insight into the clinical utility of directional atherectomy with in a broad range of patients, including diabetics, non-diabetics, claudicants, and those with critical limb-threating ischemia.
We’ve gathered useful resources for physicians interested in the HawkOne™ device, including case studies, physician interviews, and how-to videos.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.